Randomized, open-label, phase 2a study to evaluate the contribution of artefenomel to the clinical and parasiticidal activity of artefenomel plus ferroquine in African patients with uncomplicated Plasmodium falciparum malaria.

Malar J · 2023 · PMC9809015 · PMID 36597076

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Parasite clearance kinetics showed a trend for improvement in the ferroquine/artefenomel combination arms versus ferroquine alone, with no apparent trend between the different artefenomel dosing arms (Table 2 ; Additional file 5 : Table S3).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.